This initiative funds clinical research centers to study disorders of gastrointestinal interoception, expanding beyond gastroparesis to include adult and pediatric GI conditions. It emphasizes multidisciplinary approaches to understand underlying mechanisms, identify biomarkers, and develop novel therapeutic targets for future clinical trials. The consortium includes up to 6 Clinical Research Centers and a Scientific Data Research Center, leveraging advanced technologies to transform understanding and treatment of GI motility disorders.
Eligible applicants include a wide range of entities such as state, county, city, and tribal governments, public and private higher education institutions, nonprofits, for-profit organizations, small businesses, federal agencies, and non-U.S. entities. Specific eligibility details are provided in th
